Investors pummeled Eli Lilly and Co.’s stock Wednesday on the news that its experimental drug for Alzheimer’s disease failed to help patients, but a chorus of pharmaceutical analysts say they weren’t shocked by the setback.
Cornerstone Autism Center plans to hire about 30 employees in the next year in the 96-year-old Polk Building, which is undergoing a major rehab by its new owner.
John Lechleiter told local leaders Friday morning that while community engagement might not immediately impact the bottom line, it can be beneficial to a company’s ongoing mission.
The company said the expansion would help it retain 68 employees in Marion County who make an average of $28.85 per hour and hire 82 making similar wages over the next five years.
Pharmaceutical company stocks were among the winners in early trading Wednesday as Republicans’ sweeping election victory eased concerns that Democrats would enact controls on drug prices. Eli Lilly and Co. shares jumped 4 percent.
Makers of insulin became the latest target for Sen. Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
Lartruvo is the first front-line therapy approved by the FDA to treat soft tissue sarcomas since doxorubicin more than 40 years ago.
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
IEMS has been at the forefront of big data, unifying granular information into a real-time public health picture and spurring action across other government agencies.
For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.
Employers began hiring health advocates in earnest nationwide about four years ago, fueled by implementation of the Affordable Care Act and growing public awareness that provider rates and quality can differ greatly.
Founder of RepuCare, a 200-employee medical staffing company, Billie Dragoo has become one of central Indiana’s most fervent advocates for women. She’s a past CEO and board chairwoman of the National Association of Women Business Owners and co-founder of the Indiana Conference for Women.
Betty Cockrum’s job is not one for the faint of heart. As president and CEO of Planned Parenthood of Indiana and Kentucky, she is often in the spotlight, fighting to maintain reproductive and abortion services across the state. But despite the high-profile role, Cockrum says she’s actually an introvert.
Just two years after United Hospital Services pushed into Kokomo by merging with North Central Indiana Linen Service, the co-op is planning its next move—this time into northwest Indiana.
The latest local example of the sizzling market is the three-story Community Health Pavilion, which sold last week for $286 a square foot—far more than the per-square-foot price in two recent office complex transactions.
Mylan will start selling a cheaper version of the emergency allergy treatment after absorbing waves of criticism over a growing list price that made it unaffordable for many patients.
